Aradigm (US) gets computer inhaler patent:
This article was originally published in Clinica
Aradigm (US) has received a US patent for its inhalation-regulated pulmonary drug delivery system. The microprocessor-controlled device uses data on breathing to time drug delivery precisely via an inhaler. Manually activated inhalers often deliver erratic doses because patients are not able to discharge them at the optimum time. Aradigm is developing two hand-held aerosol delivery devices: SmartMist for asthma management; and AERx for delivering systemic drugs which are normally injected. The company has six US patents granted and a further 21 under review.